DGAP-News: Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million

Ladenburg, Germany, 12 August 2022 The Management Board of Heidelberg Pharma AG (FSE: HPHA) today formally adopted a resolution, with the approval of the Supervisory Board, to conduct a rights issue in the amount of up to EUR80million.